LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.

Zhisen ShenLexi LinBing CaoChongchang ZhouWenjuan HaoDong Ye

Published in: World journal of surgical oncology (2018)

LZTS2 promoter hypermethylation is associated with risk, progression, and prognosis of LSCC in a cohort of 96 human subjects; LZTS2 promoter hypermethylation is a candidate diagnostic and prognostic biomarker for LSCC.

Keyphrases

dna methylation
squamous cell carcinoma
transcription factor
gene expression
endothelial cells
induced pluripotent stem cells
radiation therapy
lymph node metastasis
rectal cancer